Navigation Links
Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
Date:12/11/2008

to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data support that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control. (vi, vii)

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. BYETTA provides sustained A1C control, low incidence of hypoglycemia when used with metformin or a thiazolidinedione, and progressive weight loss. BYETTA was approved in April 2005 and has been used by approximately one million patients since its introduction. For full prescribing information, visit www.BYETTA.com.

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney.

When BYETTA is used wit
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
2. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
3. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
4. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
5. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
6. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
7. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
8. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
9. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
10. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015  VA North Texas Health Care ... of vBloc, a technology-based, scientifically advanced weight loss ... implant called the Maestro® Rechargeable System that intermittently ... messages involving food intake and processing between the ... and customizable to meet the needs of a ...
(Date:6/3/2015)... , June 3, 2015  SurgiQuest®, Inc. ... access technologies for minimally invasive surgery (MIS) announced ... System in over 250,000 procedures.  Adoption has risen ... over last year, driven by the company,s expansion ... well as geographic expansion to over 45 countries.   ...
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "Global Neurodegenerative Diseases ... The global neurodegenerative diseases market to grow ... 2014-2019. This report covers the present ... neurodegenerative diseases market for the period 2015-2019. To ...
Breaking Medicine Technology:VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2
(Date:6/3/2015)... MD (PRWEB) June 03, 2015 On the ... a $13 billion industry by 2020 ( click here ... Markets), computer scientists believe Baltimore has the talent ... industry in which genetic code and other biological data are ... cure disease. “Baltimore contains all the elements of a ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Array ... exchange technology, has announced that CEO Jonathan Rickert will ... 2015 on June 4, 2015. The session will ... technologies are disrupting traditional business models in health care, ... value. , WHAT: Digital Transformation and the Health ...
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will ... upcoming Annual Meeting. DIA’s Global Inspire Award program recognizes ... excellence, and commitment to service on a global scale. ... Service Award that recognizes the “Member of the Year” ... and who has contributed to the advancement of DIA’s ...
(Date:6/3/2015)... The panel of independent experts has spent weeks considering ... the awards presented tonight at TU-Automotive Detroit 2015. , ... best-of-the-best can now be revealed as: , Car Maker ... rivals aside by taking the coveted Car Maker of ... panel of expert judges., Stand out comments included: ...
(Date:6/3/2015)... 2015 According to an article published ... intercepted fake oxycodone pills which actually contained the potent ... look legitimate, and even sported the “A/215” imprint common ... consuming 30 mg oxycodone to be exceptionally critical of ... buy them illegally on the street. Fentanyl is an ...
Breaking Medicine News(10 mins):Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3
... patients, study finds , MONDAY, March 8 (HealthDay News) ... they catch it early, but a new study suggests ... risk of developing the disease. , If their ophthalmologists ... in the eye won,t need to take prescription anti-glaucoma ...
... if parent had brain attack by 65, chances of same ... -- If your mother or father had a stroke by ... a stroke by that age are increased fourfold, U.S. researchers ... such as high blood pressure, obesity and smoking. These risks ...
... Virologists surprised to ... to be reactivated to an infectious form. , ... TAMPA, FL (PRWEB) February 20, 2010 -- Human herpesvirus 6 ... lasts for the rest of a person’s life. In a study funded by the ...
... , ... ... ... ...
... ... ... ... ...
... ... ... , ... , , ...
Cached Medicine News:Health News:Waiting Safe for Some at Risk of Glaucoma 2Health News:Stroke Risk Runs in the Family 2Health News:Stroke Risk Runs in the Family 3Health News:Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children, 2Health News:Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children, 3Health News:Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children, 4Health News:Infectious Virus Hides In Human Chromosomes During Latency And Can Be Passed From Parents To Their Children, 5Health News:Chicago AIDS Advocates Launch Female Condom Campaign 2Health News:Chicago AIDS Advocates Launch Female Condom Campaign 3Health News:Chicago AIDS Advocates Launch Female Condom Campaign 4Health News:Chicago AIDS Advocates Launch Female Condom Campaign 5Health News:Chicago AIDS Advocates Launch Female Condom Campaign 6Health News:Chicago AIDS Advocates Launch Female Condom Campaign 7Health News:Chicago AIDS Advocates Launch Female Condom Campaign 8Health News:SCAN Health Plan Debuts the First Mobile Resource Center Built Specifically for Seniors 2Health News:SCAN Health Plan Debuts the First Mobile Resource Center Built Specifically for Seniors 3Health News:SCAN Health Plan Debuts the First Mobile Resource Center Built Specifically for Seniors 4Health News:SCAN Health Plan Debuts the First Mobile Resource Center Built Specifically for Seniors 5Health News:Highmark and its Employees Donate $161,686 for Haiti Disaster Relief Efforts 2Health News:Highmark and its Employees Donate $161,686 for Haiti Disaster Relief Efforts 3
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The Precedent establishes a new generation of revision hip stems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
Medicine Products: